Estee Lauder has returned to organic sales growth for the first time in two years, reporting a 4.2% year-over-year increase in its most recent fiscal quarter. This improvement was driven by strong double-digit gains in skincare brands such as La Mer and Clinique, which together represented 37% of the company’s total net sales. The ‘Beauty Reimagined’ initiative contributed to this momentum by streamlining the product portfolio, optimizing promotional spend and accelerating digital engagement, resulting in a 120-basis-point improvement in gross margin compared with the prior year.

With a market capitalization of approximately $41.57 billion, Estee Lauder remains one of the largest pure-play prestige beauty companies. The company’s strong balance sheet includes $2.5 billion in available liquidity and a debt-to-EBITDA ratio of 1.8x, providing ample flexibility for share repurchases and targeted acquisitions. Management has authorized a $1.5 billion buyback program for the current fiscal year and continues to target a dividend payout ratio of 25% to 30% of adjusted net earnings.

On January 29, 2026, Deutsche Bank raised its price target for Estee Lauder to $128, implying upside of roughly 10.9% from recent trading levels. The upgrade was based on expectations for accelerating margin expansion—forecast to rise by 150 basis points over the next two quarters—and continued productivity gains in supply chain and marketing operations. This follows earlier bullish revisions from both UBS and Morgan Stanley, which cited resilient demand in North America and faster-than-expected recovery in key Asia markets.